Exigent Capital

Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard's effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA.

MaxQ-AI utilizes advanced cognitive analytics and artificial intelligence to deliver real time decision support tools to improve clinical outcomes in acute medical scenarios. The MaxQ team of artificial intelligence, machine learning, deep learning and algorithmic experts and its medical advisory boards in Israel and the United States are achieving breakthroughs in standards of cost and care.

Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard's effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA.

StorePower is powering online grocery via hosted Software as a Service. StorePower leverages our years of online experience building AbesMarket.com by providing a smart and efficient white label solutions for grocery chains to sell online.

Revelator offers the leading technology solutions for record labels, distributors, artist managers, and more. Our solutions power catalog management, metadata, delivery & distribution, reporting, royalty management, analytics, business intelligence and web3 assets.

Founded in 2006, ImmunArray is a molecular diagnostics company that developed a proprietary test to rule out the presence of the autoimmune disease lupus in blood samples. The test, which ImmunArray introduced last year, is significant because lupus is difficult to diagnose and can be mistaken for other autoimmune diseases. ImmunArray’s test helps avoid incorrect diagnosis and medication.

Liberty SBF is an experienced commercial real estate finance company. With a special expertise in small-balance commercial lending, Liberty SBF addresses the needs of small businesses facing a challenging credit environment. Through its subsidiaries, Liberty SBF utilizes a variety of conventional, CMBS, and government guaranteed loan programs that provide financing to borrowers seeking to grow their businesses and acquire commercial real estate and other assets.

MaxQ-AI utilizes advanced cognitive analytics and artificial intelligence to deliver real time decision support tools to improve clinical outcomes in acute medical scenarios. The MaxQ team of artificial intelligence, machine learning, deep learning and algorithmic experts and its medical advisory boards in Israel and the United States are achieving breakthroughs in standards of cost and care.